ABSTRACT
P99 Table 1Changes in self-reported knowledge, training, and adherence regarding inhaled therapies during COVID-19. Pattern analysis of participants reporting change in adherence indicates the role of patient emotions, beliefs, and experiences. Six reasons inducing adherence-promoting or adherence-limiting behaviour were identified.Participant identifier Change in knowledge Change in training Change in adherence Reason(s) for change in adherence 2 No change No change Fear of contracting COVID-19 22 Decreased Decreased Worsening of symptoms during COVID-19 30 No change No change Fear of contracting COVID-19;Worsening of symptoms during COVID-19 38 No change No change Increased Motivation from awareness of COPD as a COVID-19 risk factor 49 Increased No change Perception of high therapeutic benefit from new prescription during COVID-19;Motivation from awareness of COPD as a COVID-19 risk factor 17 Decreased Decreased Social isolation/depression and neglectful of COPD treatment during COVID-19 23 No change No change Decreased Improvement in symptoms during COVID-19 28 No change Decreased Social isolation/depression and neglectful of COPD treatment during COVID-19 ConclusionsDisparities between patients’ perceived and actual knowledge, deficiencies in training delivered, and potential for more appropriate inhalation device selection exist. COVID-19 induces bidirectional change in adherence;the impacts of ‘shielding’ and disruption to routine care may limit positive change. Although a larger study is required to confirm statistical significance, these findings warrant improved patient education provision.